Many oncogenic mutants
of the tumor suppressor p53 are conformationally unstable, including
the frequently occurring Y220C mutant. We have previously developed
several small-molecule stabilizers of this mutant. One of these molecules,
PhiKan083, 1-(9-ethyl-9H-carbazole-3-yl)-N-methylmethanamine,
binds to a mutation-induced surface crevice with a KD = 150 μM, thereby increasing the melting temperature
of the protein and slowing its rate of aggregation. Incorporation
of fluorine atoms into small molecule ligands can substantially improve
binding affinity to their protein targets. We have, therefore, harnessed
fluorine–protein interactions to improve the affinity of this
ligand. Step-wise introduction of fluorines at the carbazole ethyl
anchor, which is deeply buried within the binding site in the Y220C–PhiKan083
complex, led to a 5-fold increase in affinity for a 2,2,2-trifluoroethyl
anchor (ligand efficiency of 0.3 kcal mol–1 atom–1). High-resolution crystal structures of the Y220C–ligand
complexes combined with quantum chemical calculations revealed favorable
interactions of the fluorines with protein backbone carbonyl groups
(Leu145 and Trp146) and the sulfur of Cys220 at the mutation site.
Affinity gains were, however, only achieved upon trifluorination,
despite favorable interactions of the mono- and difluorinated anchors
with the binding pocket, indicating a trade-off between energetically
favorable protein–fluorine interactions and increased desolvation
penalties. Taken together, the optimized carbazole scaffold provides
a promising starting point for the development of high-affinity ligands
to reactivate the tumor suppressor function of the p53 mutant Y220C
in cancer cells.